FDG PET scan study in cancer patients
Treatments studied
Part of Cancer clinical trials.
This study looks at how certain factors affect the way a radioactive tracer called FDG is taken up by normal organs and tumors. It may help improve the accuracy of PET scans for cancer patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have cancer and be scheduled for a PET scan in a nuclear medicine unit.
- You cannot have increased FDG uptake caused by non-cancer issues like widespread bone marrow activity or a lung infection.
- You cannot have large amounts of cancer spread to the organs being studied.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special type of scan (F-18 FDG PET/CT) to better understand metabolism in adults with lymphoma. The results may help doctors plan treatment more effectively.
This trial compares different ways to measure sugar uptake in PET/CT scans for cancer. It aims to see which method gives the most accurate results to help guide your treatment.
This study compares two types of PET/CT scans—one that uses FDG and one that uses FAPI—to help doctors see and evaluate cancer in different situations. It may help improve how well scans detect tumors and guide care, though it requires getting both scans scheduled.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
This trial studies how well a specific PET/CT scan using a radioactive tracer can detect or evaluate cancers. It may help doctors see where cancer is in the body more clearly.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
Hear when a new Oncologic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.